Clinical Trial Update: Study to Test the Efficacy and Safety of Vafidemstat in Adult Borderline Personality Disorder Population [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the efficacy and safety of vafidemstat in adults with Borderline Personality Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Personality Disorder

Drugs mentioned

• vafidemstat (vafidemstat)

Snippet

Sponsor: Oryzon Genomics S.A. | Conditions: Borderline Personality Disorder | Phase 2 | Status: COMPLETED